AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease.
Clinical trial NCT02826525 · COMPLETED
Trial details
- NCT number
- NCT02826525
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-18
- Primary completion
- 2019-10-11
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.